Literature DB >> 7683202

Malignant paraganglioma with skeletal metastases and spinal cord compression: response and palliation with chemotherapy.

W C Mertens1, D J Grignon, W Romano.   

Abstract

Paragangliomas (carotid body tumours, chemodectomas) may arise in any area of the body where sympathetic ganglia are present, including chemoreceptors, the adrenal medulla and retroperitoneal ganglia. Increasing numbers of patients are being reported with vertebral metastases and spinal cord compression for which either decompression laminectomy or external beam radiotherapy, or both, are required. Patients with vertebral metastases may develop progression of disease after radiation therapy. There is little published information on the use of chemotherapy in this clinical situation. We report a case of metastatic paraganglioma complicated by spinal cord compression showing evidence of clinical benefit from chemotherapy after progressive disease and symptoms developed in a region previously treated by radiation therapy.

Entities:  

Mesh:

Year:  1993        PMID: 7683202     DOI: 10.1016/s0936-6555(05)80868-4

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

1.  Treatment and outcome of metastatic paraganglioma of the spine.

Authors:  Qi Jia; Huabin Yin; Jian Yang; Zhipeng Wu; Wangjun Yan; Wang Zhou; Xinghai Yang; Jianru Xiao
Journal:  Eur Spine J       Date:  2017-06-26       Impact factor: 3.134

2.  Bevacizumab fails to treat temporal paraganglioma: discussion and case illustration.

Authors:  Hamidreza Aliabadi; James J Vredenburgh; Richard G Everson; Annick Desjardins; Henry S Friedman; Roger E McLendon; Debara L Tucci; John H Sampson
Journal:  J Neurooncol       Date:  2009-12-19       Impact factor: 4.130

3.  Malignant head and neck paragangliomas: is there an optimal treatment strategy?

Authors:  Daniel J Moskovic; Joseph R Smolarz; Douglas Stanley; Camilo Jimenez; Michelle D Williams; Ehab Y Hanna; Michael E Kupferman
Journal:  Head Neck Oncol       Date:  2010-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.